Back to Search
KOLLAGUNTA CHANDRASEKHAR, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1396713491IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
ME64020(FL)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 1979
Research & Publications (20)
A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
PMID 19632800·J Pharm Biomed Anal·2009
8-other
Signaling hunger through aggression--the regulation of foraging in a primitively eusocial wasp.
PMID 18350266·Naturwissenschaften·2008
7-preclinical
Biosorptive removal of cadmium from contaminated groundwater and industrial effluents.
PMID 17892931·Bioresour Technol·2008
8-other
Validated enantiospecific LC method for determination of (R)-enantiomer impurity in (S)-efavirenz.
PMID 18380395·Pharmazie·2008
8-other
Immunohistochemical analysis of target proteins of Rho-kinase in a mouse model of accelerated atherosclerosis.
PMID 18651000·Exp Clin Cardiol·2007
8-other
Development of mucoadhesive patches for buccal administration of carvedilol.
PMID 17269915·Curr Drug Deliv·2007
3-trial
Development and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance.
PMID 17566333·J Sep Sci·2007
4-observational
A novel validated LC method for quantitation of lopinavir in bulk drug and pharmaceutical formulation in the presence of its potential impurities and degradation products.
PMID 17370253·Biomed Chromatogr·2007
4-observational
Development and validation of a reverse-phase liquid chromatographic method for assay and related substances of abacavir sulfate.
PMID 17313138·J Sep Sci·2007
4-observational
A stability-indicating HPLC assay method for docetaxel.
PMID 16473490·J Pharm Biomed Anal·2006
8-other
KCNE1 subunits require co-assembly with K+ channels for efficient trafficking and cell surface expression.
PMID 17065152·J Biol Chem·2006
4-observational
Active-site changes in the pyruvate dehydrogenase multienzyme complex E1 apoenzyme component from Escherichia coli observed at 2.32 A resolution.
PMID 17057342·Acta Crystallogr D Biol Crystallogr·2006
8-other
Variant origin of superior thyroid artery, occipital artery and ascending pharyngeal artery from a common trunk from the cervical segment of internal carotid artery.
PMID 17024310·Surg Radiol Anat·2006
5-case
Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate.
PMID 16563688·J Pharm Biomed Anal·2006
8-other
A thiamin-bound, pre-decarboxylation reaction intermediate analogue in the pyruvate dehydrogenase E1 subunit induces large scale disorder-to-order transformations in the enzyme and reveals novel structural features in the covalently bound adduct.
PMID 16531404·J Biol Chem·2006
8-other
A validated chiral LC method for the enantiomeric separation of Zolmitriptan key intermediate, ZTR-5.
PMID 15941641·J Pharm Biomed Anal·2005
8-other
A validated chiral liquid chromatographic method for the enantiomeric separation of Rivastigmine hydrogen tartarate, a cholinesterase inhibitor.
PMID 15925225·J Pharm Biomed Anal·2005
8-other
A validated stability indicating ion-pair RP-LC method for zoledronic acid.
PMID 15922532·J Pharm Biomed Anal·2005
8-other
A validated chiral LC method for the determination of zolmitriptan and its potential impurities.
PMID 15740903·J Pharm Biomed Anal·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 320 1ST ST. N
WINTER HAVEN, FL 33881 - Phone
- (863) 508-1101
Quick Facts
- NPI
- 1396713491
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile